Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Claus Hanusch

2PUBLICATIONS

33CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Feb 25, 2025

Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer and HRD-Long-term Survival of the GeparOLA Study.

Peter A Fasching, Sabine Schmatloch, Jan Hauke

|Sep 19, 2023

RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial.

Theresa Link, Jens-Uwe Blohmer, Wolfgang D Schmitt

Pageof 1

Frequent Collaborators

2 joint publications

Theresa Link

2 joint publications

Jens-Uwe Blohmer

2 joint publications

Wolfgang D Schmitt

2 joint publications

Kerstin Rhiem

2 joint publications

Michael Untch

2 joint publications

Valentina Nekljudova

2 joint publications

Peter A Fasching

2 joint publications

Christian Jackisch

2 joint publications

Jens Huober

2 joint publications

Andreas Schneeweiss

Frequent Collaborators

2 joint publications

Theresa Link

2 joint publications

Jens-Uwe Blohmer

2 joint publications

Wolfgang D Schmitt

2 joint publications

Kerstin Rhiem

Top Related Videos

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

Published on : Jun 14, 2021

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

See more related videos

Top Related Videos

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

Published on : Jun 14, 2021

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

See more related videos